Xarelto (rivaroxaban) will be used to TREAT venous thromboembolism
December 2012
Xarelto (rivaroxaban) will be used to TREAT venous thromboembolism.
It's the first of the new oral anticoagulants approved to treat deep venous thrombosis or pulmonary embolism...and reduce the risk of a subsequent venous thromboembolism (VTE).
Xarelto has advantages over warfarin for treating venous clots...no anticoag monitoring, fewer interactions, and no bridging with low-molecular-weight heparin because of its fast onset.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote